{
    "clinical_study": {
        "@rank": "13446", 
        "brief_summary": {
            "textblock": "In total 50 subjects with iron deficiency anemia treated with intravenous iron are planned\n      for inclusion in this trial. After signing an informed consent a blood sample will be\n      obtained from each participant before iron treatment. The investigators will measure the\n      thrombin generation in plasma assessed by the calibrated automated thrombogram (CAT).\n      patient will go face to face interview and will be asked to answer structured questionnaire\n      which will include information on demographics, clinical data ( fever, allergies , etc.) and\n      comorbidities\n\n      Two weeks after completing intravenous  iron administration additional blood samples will be\n      taken: thrombin generation  will be measured"
        }, 
        "brief_title": "The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.", 
        "condition": "Iron-Deficiency Anemias,", 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Deficiency Diseases", 
                "Anemia, Iron-Deficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age >18 years\n\n          -  Iron deficiency anemia that did not response to oral iron treatment and is planned to\n             receive iron supplement intravenously.\n\n          -  Signing the informed consent\n\n        exclusion criteria:\n\n          -  chronic inflammatory disease\n\n          -  renal failure\n\n          -  Malignancy\n\n          -  Infectious disease\n\n          -  Other reason  for anemia  except iron deficiency anemia.\n\n          -  Pregnant women\n\n          -  Use of anti aggregating agents or anticoagulants"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "men and women over age 18 suffering from iron deficiency anemia that wasnt responded to\n        oral iron treatment or there is contraindication for oral iron therapy."
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02129907", 
            "org_study_id": "thrombingeneration- anemia"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Thrombin", 
                "Iron"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Anemias", 
            "Iron-Deficiency", 
            "thrombin"
        ], 
        "lastchanged_date": "May 1, 2014", 
        "number_of_groups": "1", 
        "official_title": "The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ethics Commission", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "thrombin generation levels", 
            "safety_issue": "No", 
            "time_frame": "10 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02129907"
        }, 
        "responsible_party": {
            "investigator_affiliation": "HaEmek Medical Center, Israel", 
            "investigator_full_name": "Elias mazen", 
            "investigator_title": "prof mazen elias", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "HaEmek Medical Center, Israel", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "HaEmek Medical Center, Israel", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "10 Weeks", 
        "verification_date": "May 2014"
    }
}